CCCC
Price
$2.54
Change
-$0.04 (-1.55%)
Updated
Dec 11 closing price
Capitalization
246.16M
69 days until earnings call
Intraday BUY SELL Signals
PYXS
Price
$4.41
Change
+$0.12 (+2.80%)
Updated
Dec 11, 04:59 PM (EDT)
Capitalization
274.59M
103 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CCCC vs PYXS

Header iconCCCC vs PYXS Comparison
Open Charts CCCC vs PYXSBanner chart's image
C4 Therapeutics
Price$2.54
Change-$0.04 (-1.55%)
Volume$922.96K
Capitalization246.16M
Pyxis Oncology
Price$4.41
Change+$0.12 (+2.80%)
Volume$8.48K
Capitalization274.59M
CCCC vs PYXS Comparison Chart in %
CCCC
Daily Signal:
Gain/Loss:
PYXS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CCCC vs. PYXS commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and PYXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (CCCC: $2.54 vs. PYXS: $4.41)
Brand notoriety: CCCC and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 50% vs. PYXS: 43%
Market capitalization -- CCCC: $246.16M vs. PYXS: $274.59M
CCCC [@Biotechnology] is valued at $246.16M. PYXS’s [@Biotechnology] market capitalization is $274.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whilePYXS’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • PYXS’s FA Score: 0 green, 5 red.
According to our system of comparison, both CCCC and PYXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 4 TA indicator(s) are bullish while PYXS’s TA Score has 3 bullish TA indicator(s).

  • CCCC’s TA Score: 4 bullish, 5 bearish.
  • PYXS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than PYXS.

Price Growth

CCCC (@Biotechnology) experienced а -1.93% price change this week, while PYXS (@Biotechnology) price change was +2.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

CCCC is expected to report earnings on Feb 19, 2026.

PYXS is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PYXS($275M) has a higher market cap than CCCC($246M). PYXS YTD gains are higher at: 175.000 vs. CCCC (-29.444). PYXS has higher annual earnings (EBITDA): -83.16M vs. CCCC (-109.63M). CCCC has more cash in the bank: 215M vs. PYXS (88.9M). PYXS has less debt than CCCC: PYXS (19.5M) vs CCCC (62.9M). CCCC has higher revenues than PYXS: CCCC (34.2M) vs PYXS (2.82M).
CCCCPYXSCCCC / PYXS
Capitalization246M275M89%
EBITDA-109.63M-83.16M132%
Gain YTD-29.444175.000-17%
P/E RatioN/AN/A-
Revenue34.2M2.82M1,213%
Total Cash215M88.9M242%
Total Debt62.9M19.5M323%
TECHNICAL ANALYSIS
Technical Analysis
CCCCPYXS
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
83%
Bullish Trend 18 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signal:
Gain/Loss:
PYXS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HOCPY152.911.96
+1.30%
Hoya Corp.
TKCBY22.95N/A
N/A
Tokai Carbon Company Ltd.
MALRF27.99N/A
N/A
Mineral Resources Ltd.
BTRYF0.42N/A
N/A
WARATAH MINERALS LTD.
VINZF0.03N/A
N/A
London BTC Company Limited

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with BEAM. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-1.55%
BEAM - CCCC
42%
Loosely correlated
+0.40%
PYXS - CCCC
41%
Loosely correlated
+2.80%
AXON - CCCC
40%
Loosely correlated
+2.22%
ALGS - CCCC
40%
Loosely correlated
+1.59%
GLUE - CCCC
40%
Loosely correlated
-3.89%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with BEAM. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
-0.23%
BEAM - PYXS
51%
Loosely correlated
+3.47%
SYRE - PYXS
47%
Loosely correlated
+2.91%
ZBIO - PYXS
43%
Loosely correlated
+2.42%
CRBU - PYXS
42%
Loosely correlated
+1.60%
ERAS - PYXS
42%
Loosely correlated
-1.21%
More